AirSeal is selected as one of the seven companies to be part of TMC Innovation

Releted Post

AirSeal is selected as a recipient of the first WashU Venture Network Follow-on Investments

April 12, 2025

Our co-founder, Dr. Zayed, was recently interviewed by KMOX Radio

April 1, 2025

AirSeal is awarded a co-investment of $500,000 from Missouri Technology Corporation (MTC)

November 12, 2024

AirSeal is selected as a 2024 Arch Grants recipient, which includes a $75,000 non-dilutive cash award.

November 1, 2024

AirSeal is selected as one of the seven companies to be part of TMC Innovation Healthtech Accelerator Cohort 17. We are leveraging resources and advices from TMC to further collaborations and commercialization efforts

https://www.tmc.edu/blog/tmc-innovation-factory-hosts-cohort-17-for-its-healthtech-accelorator-bootcamp/

AirSeal is advancing early, accurate diagnosis of cardiovascular diseases through innovative biomarker technology.